Red Cross Defends Actions to Tainted-Blood Inquiry

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Red Cross Defends Actions to Tainted-Blood Inquiry

Toronto Globe and Mail (12/12/96) P. A10
Grange, Michael

Abstract: In its final submission to the federal inquiry into Canada's tainted blood tragedy, the Canadian Red Cross Society gave its perspective on how 3,000 people came to receive tainted blood. Earl Cherniak, who represented the agency, said that "mistakes were made and much can be learned from the tragedy--but to try to pin the blame for what happened on a select number of individuals or institutions is wrong." Lawyers for the Red Cross presented defense for the agency and criticism of groups that questioned how it had handled the situation. The agency also proposed that financial assistance be offered for patients infected with hepatitis C, as it was for HIV-infected individuals, and that a national system of financial assistance be established for future cases of injury from blood or blood products.

961216
AD962379

Copyright © 1996 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.